Literature DB >> 19604071

Temporal analysis of equine bone marrow aspirate during establishment of putative mesenchymal progenitor cell populations.

Catherine H Radcliffe1, M Julia B F Flaminio, Lisa A Fortier.   

Abstract

Mesenchymal progenitor cells (MPCs) are often characterized using surface markers after expansion and treatment in culture. There are no studies directly comparing gene and protein markers in undifferentiated samples during the very early phases of culture. The goal of this study was to evaluate temporal gene and protein expression changes during establishment of equine MPC cultures. Bone marrow aspirate was obtained from 35 horses and processed by density gradient centrifugation. In freshly isolated bone marrow, mononuclear cells had variable expression of CD44, CD11a/CD18, CD90, and CD45RB cell surface molecules. After 2 h of culture, bone marrow mononuclear cells had a phenotype of CD44(hi), CD29(hi), CD90(lo), CD11a/CD18(hi), and CD45RB(lo). Isolated mononuclear cells were analyzed by flow cytometry and RT-qPCR at 2, 7, 14, 21, and 30 days of culture. At all culture time points, gene expression was in agreement with cell surface protein expression. In established cultures of MPCs, cells remained robustly positive for CD44 and CD29. The proportion of positive cells and the mean fluorescence intensity of positive cells increased in CD90 expression as MPC cultures became more homogeneous. Inversely, the population of cells in culture decreased expression of CD11a/CD18 and CD45RB molecules over time. The decreased expression of the latter molecules makes these useful negative markers of established MPC cultures under normal expansion conditions. The results of this study demonstrate numerous dynamic changes in cell surface molecule expression during early establishment of MPC populations, which may aid to improve MPC isolation methods for research or therapeutic applications.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19604071      PMCID: PMC3138180          DOI: 10.1089/scd.2009.0091

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  27 in total

1.  Analysis of apoptotic cells by flow and laser scanning cytometry.

Authors:  Z Darzynkiewicz; E Bedner
Journal:  Methods Enzymol       Date:  2000       Impact factor: 1.600

2.  Peripheral blood lymphocyte subpopulations and immunoglobulin concentrations in healthy foals and foals with Rhodococcus equi pneumonia.

Authors:  M J Flaminio; B R Rush; W Shuman
Journal:  J Vet Intern Med       Date:  1999 May-Jun       Impact factor: 3.333

3.  Molecular cloning of equine CD44 cDNA by a COS cell expression system.

Authors:  A S Tavernor; E V Deverson; W J Coadwell; D P Lunn; C Zhang; W Davis; G W Butcher
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

4.  Multilineage potential of adult human mesenchymal stem cells.

Authors:  M F Pittenger; A M Mackay; S C Beck; R K Jaiswal; R Douglas; J D Mosca; M A Moorman; D W Simonetti; S Craig; D R Marshak
Journal:  Science       Date:  1999-04-02       Impact factor: 47.728

5.  Fibroblast precursors in normal and irradiated mouse hematopoietic organs.

Authors:  A J Friedenstein; J F Gorskaja; N N Kulagina
Journal:  Exp Hematol       Date:  1976-09       Impact factor: 3.084

Review 6.  Report of the First International Workshop on Equine Leucocyte Antigens, Cambridge, UK, July 1991.

Authors:  J Kydd; D F Antczak; W R Allen; D Barbis; G Butcher; W Davis; W P Duffus; N Edington; G Grünig; M A Holmes
Journal:  Vet Immunol Immunopathol       Date:  1994-07       Impact factor: 2.046

7.  Reactive oxygen species limit neutrophil life span by activating death receptor signaling.

Authors:  Dagmar Scheel-Toellner; Keqing Wang; Rachel Craddock; Paul R Webb; Helen M McGettrick; Lakhvir Kaur Assi; Neal Parkes; Louise E Clough; Erich Gulbins; Mike Salmon; Janet M Lord
Journal:  Blood       Date:  2004-07-06       Impact factor: 22.113

8.  Report of the Second Equine Leucocyte Antigen Workshop, Squaw valley, California, July 1995.

Authors:  D P Lunn; M A Holmes; D F Antczak; N Agerwal; J Baker; S Bendali-Ahcene; M Blanchard-Channell; K M Byrne; K Cannizzo; W Davis; M J Hamilton; D Hannant; T Kondo; J H Kydd; M C Monier; P F Moore; T O'Neil; B R Schram; A Sheoran; J L Stott; T Sugiura; K E Vagnoni
Journal:  Vet Immunol Immunopathol       Date:  1998-03-31       Impact factor: 2.046

9.  Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow.

Authors:  A M Mackay; S C Beck; J M Murphy; F P Barry; C O Chichester; M F Pittenger
Journal:  Tissue Eng       Date:  1998

10.  The proliferation inhibitory proteins p27(Kip1) and retinoblastoma are involved in the control of equine lymphocyte proliferation.

Authors:  M Julia B F Flaminio; Andrew Yen; Douglas F Antczak
Journal:  Vet Immunol Immunopathol       Date:  2004-12-28       Impact factor: 2.046

View more
  42 in total

1.  Analysis of CD14 expression levels in putative mesenchymal progenitor cells isolated from equine bone marrow.

Authors:  Catherine H Hackett; Maria Julia B F Flaminio; Lisa A Fortier
Journal:  Stem Cells Dev       Date:  2010-10-12       Impact factor: 3.272

2.  Evaluation of adipose-derived stromal vascular fraction from the lateral tailhead, inguinal region, and mesentery of horses.

Authors:  Garrett L Metcalf; Scott R McClure; Jesse M Hostetter; Rudy F Martinez; Chong Wang
Journal:  Can J Vet Res       Date:  2016-10       Impact factor: 1.310

3.  Comparison of gene-specific DNA methylation patterns in equine induced pluripotent stem cell lines with cells derived from equine adult and fetal tissues.

Authors:  Catherine H Hackett; Line Greve; Kira D Novakofski; Lisa A Fortier
Journal:  Stem Cells Dev       Date:  2011-11-21       Impact factor: 3.272

4.  Immunophenotypic characterization and tenogenic differentiation of mesenchymal stromal cells isolated from equine umbilical cord blood.

Authors:  Niharika Mohanty; Baldev R Gulati; Rajesh Kumar; Sandeep Gera; Pawan Kumar; Rajesh K Somasundaram; Sandeep Kumar
Journal:  In Vitro Cell Dev Biol Anim       Date:  2014-01-11       Impact factor: 2.416

5.  Effects of autologous stromal cells and cytokines on differentiation of equine bone marrow-derived progenitor cells.

Authors:  Ute E Schwab; Rebecca L Tallmadge; Mary Beth Matychak; M Julia B Felippe
Journal:  Am J Vet Res       Date:  2017-10       Impact factor: 1.156

6.  Homing and reparative effect of intra-articular injection of autologus mesenchymal stem cells in osteoarthritic animal model.

Authors:  Abir N Mokbel; Omar S El Tookhy; Ashraf A Shamaa; Laila A Rashed; Dina Sabry; Abeer M El Sayed
Journal:  BMC Musculoskelet Disord       Date:  2011-11-15       Impact factor: 2.362

7.  Application of a novel sorting system for equine mesenchymal stem cells (MSCs).

Authors:  Catherine L Radtke; Rodolfo Nino-Fong; Blanca P Esparza Gonzalez; Laurie A McDuffee
Journal:  Can J Vet Res       Date:  2014-10       Impact factor: 1.310

Review 8.  Therapeutic mesenchymal stromal stem cells: Isolation, characterization and role in equine regenerative medicine and metabolic disorders.

Authors:  Mohamad Al Naem; Lynda Bourebaba; Katarzyna Kucharczyk; Michael Röcken; Krzysztof Marycz
Journal:  Stem Cell Rev Rep       Date:  2020-04       Impact factor: 5.739

9.  Minimally Manipulated Bone Marrow Concentrate Compared with Microfracture Treatment of Full-Thickness Chondral Defects: A One-Year Study in an Equine Model.

Authors:  Constance R Chu; Lisa A Fortier; Ashley Williams; Karin A Payne; Taralyn M McCarrel; Megan E Bowers; Diego Jaramillo
Journal:  J Bone Joint Surg Am       Date:  2018-01-17       Impact factor: 5.284

10.  A Comparison of Bone Marrow and Cord Blood Mesenchymal Stem Cells for Cartilage Self-Assembly.

Authors:  Jamie L White; Naomi J Walker; Jerry C Hu; Dori L Borjesson; Kyriacos A Athanasiou
Journal:  Tissue Eng Part A       Date:  2018-04-02       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.